ArticleMMWR. Morbidity and mortality weekly report2019
Progress Toward Poliomyelitis Eradication - Nigeria, January 2018-May 2019.
Article in MMWR. Morbidity and mortality weekly report, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The practice of evaluating epidemic response in humanitarian and low-income settings: a systematic review.BMC medicine · 2020Pooled it
- Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India.Journal of the Pediatric Infectious Diseases Society · 2022Trial
- Exploring supplemental immunization strategies to reach zero-dose children in low- and middle-income countries: a scoping review.Therapeutic advances in vaccines and immunotherapy · 2026Article
- Overcoming barriers to polio eradication in challenging subnational geographies: lessons from South Khyber Pakhtunkhwa, Pakistan, 2022-2024.Frontiers in public health · 2026Article
- Impediments to Progress Toward Polio Eradication During 2014-2024: Effectively Addressing the Current Challenges.Vaccines · 2025Review
- Poliomyelitis in Nigeria: Impact of Vaccination Services and Polio Intervention and Eradication Efforts.Vaccines · 2025Review
- The global poliovirus eradication initiatives in Kano state, Nigeria: a case report on the African regional commission pre-certification visit and lessons learnt.Frontiers in public health · 2025Review
- Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria.Vaccine: X · 2024Article
- Lessons from polio eradication: a synthesis of implementation strategies for global health services delivery from a scoping review.Frontiers in health services · 2024Article
- Prevalence of vaccine-derived poliovirus in sewage waters in Maiduguri, Borno State, Nigeria.Le infezioni in medicina · 2024Article
- Polio vaccination activities in conflict-affected areas.Human vaccines & immunotherapeutics · 2023Review
- Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine.Vaccine · 2023Article
- Historical reconstruction of inaccessibility status in Local Government Areas (LGAs) of Borno and Yobe States, Nigeria, 2010-2020.The Pan African medical journal · 2023Article
- Experience and findings from surveillance peer review in Nigeria, August 2017-May 2019.The Pan African medical journal · 2023Article
- Descriptive epidemiology of poliomyelitis cases due to wild poliovirus type 1 and wild poliovirus type 3 in Nigeria, 2000-2020.The Pan African medical journal · 2023Article
- Assessment of open data kit mobile technology adoption to enhance reporting of supportive supervision conducted for oral poliovirus vaccine supplementary immunization activities in Nigeria, March 2017-February 2020.The Pan African medical journal · 2023Article
- Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria.Risk analysis : an official publication of the Society for Risk Analysis · 2021Article
- Article
- A comparative assessment of cold chain management using the outbreak of circulating vaccine-derived polio virus type 2 as a surrogate marker in Oyo State, Nigeria-2019.The Pan African medical journal · 2020Article
- Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2018-June 2019.MMWR. Morbidity and mortality weekly report · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The number of wild poliovirus (WPV) cases in Nigeria decreased from 1,122 in 2006 to six WPV type 1 (WPV1) in 2014 (1). During August 2014-July 2016, no WPV cases were detected; during August-September 2016, four cases were reported in Borno State. An insurgency in northeastern Nigeria had resulted in 468,800 children aged <5 years deprived of health services in Borno by 2016. Military activities in mid-2016 freed isolated families to travel to camps, where the four WPV1 cases were detected. Oral poliovirus vaccine (OPV) campaigns were intensified during August 2016-December 2017; since October 2016, no WPV has been detected (2). Vaccination activities in insurgent-held areas are conducted by security forces; however, 60,000 unvaccinated children remain in unreached settlements. Since 2018, circulating vaccine-derived poliovirus type 2 (cVDPV2) has emerged and spread from Nigeria to Niger and Cameroon; outbreak responses to date have not interrupted transmission. This report describes progress in Nigeria polio eradication activities during January 2018-May 2019 and updates the previous report (2). Interruption of cVDPV2 transmission in Nigeria will need increased efforts to improve campaign quality and include insurgent-held areas. Progress in surveillance and immunization activities will continue to be reviewed, potentially allowing certification of interruption of WPV transmission in Africa in 2020.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.